Abstract:Abstract Atopic dermatitis (AD) is a common, relapsing–remitting inflammatory skin disease that is associated with other disorders such as food allergy, allergic asthma and rhinitis, leading to increased rates of morbidity and mortality. The discovery of CD1a involvement in AD pathogenesis through the presentation of permissive neolipid antigens generated by house dust mite phospholipase A2 (PLA2) enhanced our understanding of the complex network of T-cell targets that contribute to disease development. As well as defining agonist lipids, it is now known that very long-chain sphingomyelins can act as natural lipid antagonists of CD1a–T-cell receptor (TCR) engagement. We sought to determine whether bacterial sphingomyelinases (SMases) could also activate CD1a-reactive T cells and help explain the known bacterial infection-associated manifestations of AD. An isoelectric focusing system was used to evaluate the hydrolytic capacity of bacterial SMases on very long-chain CD1a-preferred sphingomyelins. Additionally, this approach permitted examination of the impact of cobalt and nickel ions on bacterial SMase activity. Furthermore, using primary human T-cell clones and TCR transfer with CRISPR Homology Directed Repair, we evaluated SMase-reactive CD1a-dependent T-cell responses. Moreover, we examined both lesional and nonlesional skin from patients with AD, patients with psoriasis and healthy controls using RNA-Seq. Bacterial SMases were able to digest CD1a-selected sphingomyelins, and the enzymatic activity was potentiated by the presence of divalent metal ions, which are known contact dermatitis allergens. Furthermore, bacterial SMase-reactive CD1a-dependent T-cell responses were identified through markedly increased detection of AD-associated inflammatory cytokines and elevated activation marker expression. Consistency of responses between the primary T-cell clones and HDR T cells confirmed that these responses were indeed TCR specific. Skin transcriptomic changes included altered lipid processing pathways, in particular, mammalian SMase and PLA2-mediated pathways, activated in lesional tissue. We showed that bacterial SMases can effectively degrade very long-chain antagonist sphingomyelins and potentiate CD1a-reactive T-cell responses. In addition, our bioinformatics analysis revealed enhanced expression of mammalian SMases in lesional AD and psoriasis, suggesting potential broad involvement of this enzyme class in skin inflammation. This study extends our understanding of the role of lipid-metabolizing enzymes to CD1a-dependent T-cell activation in AD pathology, as well as defining a hitherto unknown pathway of contact dermatitis. The mechanisms provide insights towards novel targets for therapeutic intervention. The principal investigator has received relevant research collaboration support from UCB and Janssen. The principal investigator and some members of the group are on patents filed on CD1a.

The role of PAR2 in regulating MIF release in house dust mite-induced atopic dermatitis

Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis

House dust mite allergens induce interleukin 33 (IL-33) synthesis and release from keratinocytes via ATP-mediated extracellular signaling

Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis

Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation

Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions

Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases

Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human

A Heat-Killed Probiotic Mixture Regulates Immune T Cells Balance and IgE Production in House Dust Mite Extraction-Induced Atopic Dermatitis Mice

Role of LECT2 in exacerbating atopic dermatitis: insight from in vivo and in vitro models via NF-κB signaling pathway

41 S100A8/A9, a Damp Molecule Activated by IL-17 and House Dust Mite is Upregulated in Atopic Dermatitis

House dust mite allergen directly activates ILC2 cells via the TLR4 signaling pathway in allergic airway diseases

Systematic Characterization of the Group 2 House Dust Mite Allergen in Dermatophagoides microceras

Epicutaneous house dust mite (HDM)-induced skin lesions feature early activation of T helper 2 inflammatory and pruritogenic pathways in HDM-nonsensitised dogs

House dust mite allergens induce Ca2+ signalling and alarmin responses in asthma airway epithelial cells

Innate immune response of alveolar macrophage to house dust mite allergen is mediated through TLR2/-4 co-activation

Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity

MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity

CD15 The role of lipid-metabolizing enzymes in CD1a-associated cutaneous inflammation

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis

Interactions between Malassezia and New Therapeutic Agents in Atopic Dermatitis Affecting Skin Barrier and Inflammation in Recombinant Human Epidermis Model